The abnormal accumulation of amyloid-beta peptide(1-42) (Aβ42) is linked via several proposed pathways to the observed proteostatic stress and dyshomeostasis in the brain of AD patients (3, 4, 5, 6). This evidence concerns the gene APP and Alzheimer disease.